TrialPloS one2022

Randomized, placebo controlled phase I trial of the safety, pharmacokinetics, pharmacodynamics and acceptability of a 90 day tenofovir plus levonorgestrel vaginal ring used continuously or cyclically in women: The CONRAD 138 study.

Andrea R Thurman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.